The Claim
Dysbiosis of the gut microbiota in rheumatoid arthritis reduces systemic levels of short-chain fatty acids, leading to impaired epigenetic regulation of T cell differentiation and a pro-inflammatory Th17/Treg imbalance.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with rheumatoid arthritis, an altered gut microbiome is associated with lower levels of short-chain fatty acids in the bloodstream, which results in altered epigenetic control of T cell development and a shift toward inflammatory T cell populations.
See the scientific wording
Dysbiosis of the gut microbiota in rheumatoid arthritis reduces systemic levels of short-chain fatty acids, which weakens epigenetic regulation of T cell differentiation and promotes a pro-inflammatory Th17/Treg imbalance.
Bad gut bacteria in rheumatoid arthritis produce fewer short-chain fatty acids, which normally keep immune cells calm. Without these fatty acids, immune cells called T cells change into inflammatory types instead of calming types, leading to joint damage.
What the research says
1 studyIn rheumatoid arthritis, bad gut bacteria may produce chemicals that confuse the immune system, making it attack the body instead of calming down. This study shows that gut bacteria influence immune cell behavior through chemical signals that change how genes work, supporting the idea that gut health affects joint inflammation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.